Breast implants and anaplastic large cell lymphoma: A Danish population-based cohort study.
Vase MO, Friis S, Bautz A, Bendix K, Sørensen HT, d’Amore F.
Cancer Epidemiol Biomarkers Prev. 2013 Aug 16. [Epub ahead of print]

Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission is associated with low positive predictive value and high costs . El-Galaly T, Mylam KJ, Brown P, Specht L, Christiansen I, Munksgaard L, Johnsen HE, Loft A, Bukh A, Iyer V, Lerberg Nielsen A, Hutchings M. Haematologica. 2012;97(6):931-6

Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/ Computed Tomography-Staged Treatment-Naive Patients With Hodgkin Lymphoma . El-Galaly TC, d’Amore F, Mylam KJ, de Nully Brown P, Bøgsted M, Bukh A, Specht L, Loft A, Iyer V, Hjorthaug K, Nielsen AL, Christiansen I, Madsen C, Johnsen HE, Hutchings M. J Clin Oncol. 2012;30(36):4508-14

Differential case reporting in a national clinical quality database: an analysis of the impact on comparison of outcome between departments.
Mårtensson S, Frederiksen BL, De Nully Brown P, Dalton SO, Osler M.
Qual Manag Health Care. 2012 ;21(4):278-85.

Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark–a nationwide study. Frederiksen BL, Dalton SO, Osler M, Steding-Jessen M, de Nully Brown P.
Br J Cancer. 2012 Feb 28;106(5):988-95.

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group.

Gang AO, Strøm C, Pedersen M, d’Amore F, Pedersen LM, Bukh A, Pedersen BB, Moeller MB, Mortensen LS, Gadeberg OV, Ingeberg S, Mourits-Andersen T, Pulczynski S, d Nully Brown P.
Ann Oncol. 2012 Jan;23(1):147-53.


Conditional survival of patients with diffuse large B-cell lymphoma. Moller-MB, Pedersen-NT, Christensen-BE. Cancer. 2006 may 15.106(10):2165-70

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation–a population-based study of 1575 cases. Moller-MB, Pedersen-NT, Christensen-BE. Br J Haematol. 2004 Jan;124(2):151-9.

Molecular control of the cell cycle in cancer: biological and clinical aspects. Moller,-M-B Dan-Med-Bull. 2003 May; 50(2): 118-38

Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma.
Møller MB, Pedersen NT, Christensen BE.
Am J Hematol. 2003 Oct;74(2):94-8.

Prognosis of localized diffuse large B-cell lymphoma in younger patients. Moller,-M-B; Christensen,-B-E; Pedersen,-N-T Cancer. 2003 Aug 1; 98(3): 516-21

A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Andersen,-N-S; Jensen,-M-K; de-Nully-Brown,-P; Geisler,-C-H Eur-J-Cancer. 2002 Feb; 38(3): 401-8

2000 and previous

Non-Hodgkin’s lymphoma subtypes over time in an unselected population of 646 patients: a study of clinico-pathological data and incidence based on a review using the REAL-classification. Brincker H, Pedersen NT, Bendix-Hansen K, Johansen P.
Leuk Lymphoma. 2000 Nov;39(5-6):531-41.

CB/CC diffuse lymphoma: a distinct subtype of non-Hodgkin’s lymphoma? A study of 1593 patients from a Danish population-based registry. Danish LYFO Study Group. Munksgaard,-L; Christensen,-B-E; Brincker,-H; Pedersen,-N-T Ann-Oncol. 1997; 8 Suppl 2: 25-8

Epstein-Barr virus genome in non-Hodgkin’s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. d’Amore,-F; Johansen,-P; Houmand,-A; Weisenburger,-D-D; Mortensen,-L-S Blood. 1996 Feb 1; 87(3): 1045-55

Association of testicular non-Hodgkin’s lymphomas with elevated serum levels of human chorionic gonadotropin-like material. Moller,-M-B Oncology. 1996 Mar-Apr; 53(2): 94-8

Primaere cerebrale non-Hodgkins lymfomer og primaere maligne hjernetumorer i et veldefineret geografisk omrade. Populationsbaserede data fra det vestdanske non-Hodgkins lymfom-register, LYFO, og Cancerregisteret, Kraeftens Bekaempelse. Jensen,-M-K; d’Amore,-F-A; Jensen,-M-K; Christensen,-B-E; Thorling,-K; Pedersen,-M; Johansen,-P; Boesen,-A-M; Andersen,-E Ugeskr-Laeger. 1996 Jul 29; 158(31): 4406-12

Behandlingsresultater ved lokaliserede non-Hodgkin-lymfomer i ventriklen. En retrospektiv undersogelse af 106 tilfaelde. Brincker,-H Ugeskr-Laeger. 1996 Aug 5; 158(32): 4520-3

A retrospective analysis of treatment outcome in 106 cases of localized gastric non-Hodgkin lymphomas. Danish Lymphoma Study Group, LYFO. Brincker,-H; D’Amore,-F Leuk-Lymphoma. 1995 Jul; 18(3-4): 281-8

Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Krogh-Jensen,-M; D’Amore,-F; Jensen,-M-K; Christensen,-B-E; Thorling,-K; Pedersen,-M; Johansen,-P; Boesen,-A-M; Andersen,-E Leuk-Lymphoma. 1995 Oct; 19(3-4): 223-33

Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. d’Amore,-F; Brincker,-H; Gronbaek,-K; Thorling,-K; Pedersen,-M; Jensen,-M-K; Andersen,-E; Pedersen,-N-T; Mortensen,-L-S J-Clin-Oncol. 1994 Aug; 12(8): 1673-84

Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Krogh-Jensen,-M; d’Amore,-F; Jensen,-M-K; Christensen,-B-E; Thorling,-K; Pedersen,-M; Johansen,-P; Boesen,-A-M; Andersen,-EAnn-Oncol. 1994 Apr; 5(4): 349-54

Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.Moller,-M-B; d’Amore,-F; Christensen,-B-E Eur-J-Cancer. 1994; 30A(12): 1760-4

Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin’s lymphomas. Population-based data from a Danish lymphoma registry.
D’Amore F, Christensen BE, Thorling K, Pedersen M, Jensen MK, Boesen AM, Andersen E, Johansen P, Mortensen LS. Leuk Lymphoma. 1993 Dec;12(1-2):69-77.

Non-Hodgkin lymphoma in the elderly
d’Amore FA, Brincker H, Christensen BE, Thorling K, Pedersen M, Nielsen JL, Sandberg E, Pedersen NT, Sørensen E. Ugeskr Laeger. 1993 Nov 15;155(46):3754-9. Danish.

Non-Hodgkin’s lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group.
d’Amore F, Brincker H, Christensen BE, Thorling K, Pedersen M, Nielsen JL, Sandberg E, Pedersen NT, Sørensen E. Ann Oncol. 1992 May;3(5):379-86.

Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. d’Amore,-F; Christensen,-B-E; Brincker,-H; Pedersen,-N-T; Thorling,-K; Hastrup,-J; Pedersen,-M; Jensen,-M-K; Johansen,-P; Andersen,-E; et-al. Eur-J-Cancer. 1991; 27(10): 1201-8

Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cisplatin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin’s lymphoma of high grade malignancy. The Danish Lymphoma Study Group.
Andersen J, Thorling K, Bentzen SM, Brincker H, Christensen BE, Pedersen M.
Acta Oncol. 1990;29(8):995-9.

A clinicopathological study of 13 Danish Cases of Burkitt’s lymphoma.
Kerndrup G, Pallesen G.
Scand J Haematol. 1981 Aug;27(2):99-107.